Hossam M. Ashour
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 17
- Endocrinology top 1%
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 6
- SARS-CoV-2 and COVID-19 Research 4
- Food Science top 1%
-
- Immunotherapy and Immune Responses 10
- T-cell and B-cell Immunology 6
-
- Pharmaceutical and Antibiotic Environmental Impacts 8
-
- Bacterial biofilms and quorum sensing 7
-
- Ocular Surface and Contact Lens 4
- Co-authors
- Walid F. ElkhatibMd. Masudur RahmanReham WasfiHatem A. ElshabrawyMohamed E. El ZowalatyMd. Tanvir RahmanMd. Abdus SoburMd. Saiful Islam
- Partner nations
- United StatesEgyptBangladesh
In The Last Decade
Hossam M. Ashour
63 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Molecular Medicine 784
- Applied Microbiology and Biotechnology 174
- Endocrinology 330
- Infectious Diseases 799
- Food Science 617
Countries citing papers authored by Hossam M. Ashour
This map shows the geographic impact of Hossam M. Ashour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hossam M. Ashour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hossam M. Ashour more than expected).
Fields of papers citing papers by Hossam M. Ashour
This network shows the impact of papers produced by Hossam M. Ashour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hossam M. Ashour. The network helps show where Hossam M. Ashour may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hossam M. Ashour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 26 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 16 | |
| 4 | 2023 | 8 | |
| 5 | Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunitiesbreakdown → | 2023 | 121 |
| 6 | 2022 | 3 | |
| 7 | 2022 | 3 | |
| 8 | 2021 | 54 | |
| 9 | 2021 | 37 | |
| 10 | 2021 | 23 | |
| 11 | 2021 | 43 | |
| 12 | 2021 | 2 | |
| 13 | Zoonotic Diseases: Etiology, Impact, and Controlbreakdown → | 2020 | 428 |
| 14 | 2020 | 13 | |
| 15 | 2020 | 45 | |
| 16 | 2020 | 23 | |
| 17 | 2013 | 23 | |
| 18 | 2008 | 34 | |
| 19 | 2006 | 47 | |
| 20 | 2006 | 52 |
About Hossam M. Ashour
Hossam M. Ashour is a scholar working on Molecular Medicine, Endocrinology and Applied Microbiology and Biotechnology, having authored 65 papers that have together received 3.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (17 papers), Immunotherapy and Immune Responses (10 papers), Pharmaceutical and Antibiotic Environmental Impacts (8 papers), Bacterial biofilms and quorum sensing (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), T-cell and B-cell Immunology (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Ocular Surface and Contact Lens (4 papers). The work is most often cited by research in Molecular Medicine (784 citations), Applied Microbiology and Biotechnology (174 citations) and Endocrinology (330 citations). Hossam M. Ashour has collaborated with scholars based in United States, Egypt and Bangladesh. Frequent co-authors include Walid F. Elkhatib, Md. Masudur Rahman, Reham Wasfi, Hatem A. Elshabrawy, Mohamed E. El Zowalaty, Md. Tanvir Rahman, Md. Abdus Sobur, Md. Saiful Islam, Amany El-Sharif and Ola A. Abd El‐Rahman. Their work appears in journals such as Future Microbiology, Biomedicines, Antibiotics, Scientific Reports and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.